1-216175422-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_206933.4(USH2A):c.4457G>A(p.Arg1486Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.634 in 1,613,420 control chromosomes in the GnomAD database, including 326,396 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1486G) has been classified as Benign.
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
USH2A | NM_206933.4 | c.4457G>A | p.Arg1486Lys | missense_variant | 21/72 | ENST00000307340.8 | |
USH2A | NM_007123.6 | c.4457G>A | p.Arg1486Lys | missense_variant | 21/21 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.4457G>A | p.Arg1486Lys | missense_variant | 21/72 | 1 | NM_206933.4 | P1 | |
USH2A | ENST00000366942.3 | c.4457G>A | p.Arg1486Lys | missense_variant | 21/21 | 1 | |||
USH2A | ENST00000674083.1 | c.4457G>A | p.Arg1486Lys | missense_variant | 21/73 |
Frequencies
GnomAD3 genomes AF: 0.629 AC: 95572AN: 151932Hom.: 30303 Cov.: 32
GnomAD3 exomes AF: 0.661 AC: 165406AN: 250414Hom.: 55252 AF XY: 0.659 AC XY: 89168AN XY: 135334
GnomAD4 exome AF: 0.635 AC: 927401AN: 1461370Hom.: 296072 Cov.: 71 AF XY: 0.635 AC XY: 461871AN XY: 726974
GnomAD4 genome AF: 0.629 AC: 95627AN: 152050Hom.: 30324 Cov.: 32 AF XY: 0.636 AC XY: 47233AN XY: 74316
ClinVar
Submissions by phenotype
not specified Benign:4
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 02, 2012 | Inferred frequency = 141/386 (LMM data) - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 10, 2023 | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 29, 2023 | - - |
Usher syndrome type 2A Benign:2
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 18, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 01, 2021 | - - |
Retinal dystrophy Benign:1
Benign, criteria provided, single submitter | research | Dept Of Ophthalmology, Nagoya University | Oct 01, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at